Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2003-12-18
2009-02-17
Weber, Jon P (Department: 1657)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007230
Reexamination Certificate
active
07491505
ABSTRACT:
The invention concerns a method for analyzing tumor agressivity of cancer cells comprising measurement of the amount of stationary polymerized actin in a lysate of said cells. Advantageously, the measurement of the amount of stationary actin is carried out by fluorescence static polarization.
REFERENCES:
patent: 5851786 (1998-12-01), Johnson
patent: 99/11814 (1999-03-01), None
patent: 01/41815 (2001-06-01), None
patent: 01/71356 (2001-09-01), None
Tellam et al. Increased Actin Nucleating Activity in Tumerigenic Cells; Biochemical and Biophysical Research Communications, vol. 134, No. 3 (1986) pp. 1284-1290.
Malicka-Blaszkiewicz et al. Actin Content and Polymerization in Tumour, Liver and Serum of the Hepatoma Morris 5123 Tumour Bearing Rats; Materia Medica Polona, vol. 27, No. 3 (1995) pp. 115-118.
Menu et al. The F-Actin Content of Multiple Myeloma Cells as a Measure of Their Migration; Ann. N.Y. Acad. Sci., vol. 973 (2002) pp. 124-134.
Damiano, J. S. et al. (2001). “Cell adhesion mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation.” Leukemia 15(8):1232-9.
Faute, M. A. et al. (2002). “Distinctive alterations of invasiveness, drug resistance and cell-cell organization in 3D cultures of NCF-7, a human breast cancer cell line, and its multidrug resistant variant.” Clin Exp Metastasis 19(2): 161-8.
Dugray, A. et al. (2001). “Rapid generation of a tetracycline-inducible BCR-ABL defective retrovirus using a single autoregulatory retroviral cassette.” Leukemia 15: 1658-62.
Fradelizi, J. et al. (2001). “ActA and human zyxin harbour Arp2/3-independent acting polymerization activity.” Nat Cell Biol 3(8) 699-707.
Lopes, E. C. et al. (2001), “Dissimilar invasive and metastatic behavior of vincriatine and doxorubicin-resistant cell lines derived from a murine T cell lymphoid leukemia.” Clin Exp Metastasis 19(4): 283-90.
Machesky, L. M. et al. (1999). “Scar, a WASp-related protein, activates nucleation of actin filaments by the Arp2/3 complex.” Proc Natl Acad Sci U S A 96(7): 3739-44.
Mitsumoto, M. et al. (1998). “Emergence of higher levels of invasive and metastatic properties in the drug-resistant cancer cell lines after the repeated administration of cisplatin in tumor-bearing mice.” J Cancer Res Clin Oncol 124(11): 607-14.
Nakamura, K. et al. (2002). “Characterization of murine melanoma cell lines by their mortal malignancy using an experimental metastatic model.” Life Sci 70(7): 791-8.
Auclair Christian
Polard Valérie
Pragnon Christelle
Subra Frèdèric
Arent & Fox LLP
Bioalliance Pharma
Centre National de la Recherche Scientifique--CNRS
Ens Cachan
Martin Paul C.
LandOfFree
Method for analyzing tumor aggressivity comprising... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for analyzing tumor aggressivity comprising..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for analyzing tumor aggressivity comprising... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4088863